Phibro Animal Health Corporation
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +94.8% | -63.9% | +149.2% | -55.6% | -75.6% | +1,302.9% | -50.7% | -56.3% | +108.0% | -16.3% | +48.7% | – | |
| – | +0.4% | +3.2% | +0.1% | -2.1% | +28.5% | +9.0% | -1.6% | +3.4% | +0.5% | -3.4% | +7.2% | – | |
| – | -1.2% | +68.8% | +32.6% | +0.0% | +0.6% | -0.6% | +0.0% | +89.4% | +28.0% | -5.3% | +0.5% | – | |
| – | +528.5% | -152.9% | – | -90.6% | -1,003.7% | – | -269.1% | – | – | – | – | – | |
| – | +46.6% | -11.2% | +34.3% | -26.7% | -18.4% | -1.0% | +69.7% | +5.1% | -19.6% | +38.0% | +23.2% | – | |
| – | +61.9% | – | -906.3% | -67.8% | +8,789.9% | -93.0% | -61.5% | +198.7% | -18.2% | -2.2% | -2.1% | – | |
| – | +0.0% | 0.0% | +0.0% | 0.0% | +0.0% | +0.1% | 0.0% | +0.0% | +0.0% | +0.1% | 0.0% | – | |
| – | – | – | – | – | – | -109.2% | -65.2% | – | -150.4% | – | -177.8% | – | |
| – | -1,234.6% | – | -63.2% | -1,733.9% | – | -111.7% | -75.9% | – | -216.2% | -87.9% | -29.8% | – | |
| – | -644.0% | – | +18.2% | -192.1% | – | -144.1% | – | -38.5% | -465.4% | – | – | – | |
| – | +136.1% | -91.9% | +815.7% | -80.2% | -256.2% | – | -77.0% | -155.4% | – | -89.2% | +487.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.